ProMIS Neurosciences, Inc. (PMN) – A clinical-stage biotech company developing antibody therapies targeting toxic misfolded proteins linked to neurodegenerative diseases like Alzheimer’s, ALS, and Parkinson’s.
Trade closed: target reached
TP HIT! 💹
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.